MetaCap

Bullfrog AI (BFRG) vs FibroBiologics (FBLG)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bullfrog AI is the larger company by market cap ($6.6 million vs $6.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BFRG-49.82%FBLG-38.16%
+2%-25%-52%
Oct 7, 20261 yearNov 20, 2026
BFRG-44.95%FBLG-37.61%
+2%-22%-47%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BFRG versus FBLG key metrics
MetricBFRGFBLG
Share price$0.3556$0.705
Market cap$6.65M$6.34M
1-day change-8.84%-15.06%
YTD return-59.73%—
1-year return-58.21%—
EPS (TTM)$-0.41$-2.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$116.67K—
Net income (latest FY)$-6.50M$-18.65M
Gross margin18.76%—
Operating margin-5652.38%—
Net margin-5569.61%—
52-week high$1.96$9.60
52-week low$0.35$0.62
Distance from 52-week high-81.86%-92.66%
Analyst consensusnonenone
Avg. price target upside—+1673.05%
Average volume5.38M160.05K
Shares outstanding18.69M8.99M
Employees915
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Bullfrog AI

BFRG stock →

Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees

About FibroBiologics

FBLG stock →

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.

Health Care · Biotechnology: Pharmaceutical Preparations · 15 employees

BFRG vs FBLG FAQ

Which is bigger, Bullfrog AI or FibroBiologics?

Bullfrog AI (BFRG) is larger, with a market capitalization of $6.65M compared with $6.34M for FibroBiologics (FBLG).

Are Bullfrog AI and FibroBiologics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons